Factors affecting transplant outcomes in diabetic nude mice receiving human, porcine, and nonhuman primate islets: Analysis of 335 transplantations

Transplantation

Volumn 95, Issue 12, 2013, Pages 1439-1447

  Loganathan, Gopalakrishnan ^a   Graham, Melanie L ^a   Radosevich, David M ^a   Soltani, Sajjad M ^a   Tiwari, Mukesh ^a   Anazawa, Takayuki ^a,b   Papas, Klearchos K ^a,c   Sutherland, David E R ^a   Hering, Bernhard J ^a   Balamurugan, A N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Human islets; Islet cell transplantation; Nude mice bioassay; Nude mice transplant; Porcine islets and nonhuman primate islets

Indexed keywords

INSULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DONOR; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; ISLET MASS; ISLET PELLET SIZE; ISLET PURITY; MALE; MEDICAL PARAMETERS; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; SWINE; TREATMENT OUTCOME;

ADULT; ANIMALS; BIOLOGICAL ASSAY; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA FASCICULARIS; MACACA MULATTA; MALE; MICE; MICE, NUDE; MIDDLE AGED; PAPIO; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84880136008     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318293b7b8     Document Type: Article

References (28)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosup-pression: Miami experience. Am J Transplant 2005; 5: 2037.
3. Hering BJ, Walawalkar N. Pig-to-nonhuman primate islet xeno-transplantation. Transpl Immunol 2009; 21: 81.
4. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185.
5. Caiazzo R, Gmyr V, Kremer B, et al. Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation. Transplantation 2008; 86: 360.
6. Piemonti L, Bertuzzi F, Nano R, et al. Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation 1999; 68: 655.
7. Bertuzzi F, Saccomanno K, Socci C, et al. Long-term in vitro exposure to high glucose increases proinsulin-like-molecules release by isolated human islets. J Endocrinol 1998; 158: 205.
8. Ling Z, Pipeleers DG. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 1996; 98: 2805.
9. Merani S, Schur C, Truong W, et al. Compaction of islets is detrimental to transplant outcome in mice. Transplantation 2006; 82: 1472.
10. Migliavacca B, Nano R, Antonioli B, et al. Identification of in vitro parameters predictive of graft function: a study in an animal model of islet transplantation. Transplant Proc 2004; 36: 612.
11. Loganathan G, Dawra RK, Pugazhenthi S, et al. Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of alpha-1 antitrypsin treatment. Transplantation 2011; 92: 1222.
12. Montana E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 1993; 91: 780.
13. Merino JF, Nacher V, Raurell M, et al. Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function. Diabetologia 1997; 40: 1004.
14. Graham ML, Bellin MD, Papas KK, et al. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011; 18: 328.
15. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120.
16. Mueller KR, Balamurugan AN, Cline GW, et al. Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin. Xenotransplantation 2013; 20: 75.
17. Gray DW, Sutton R, McShane P, et al. Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule. J Surg Res 1988; 45: 432.
18. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007; 7: 707.
19. Rood PP, Bottino R, Balamurugan AN, et al. Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas 2006; 33: 287.
20. Balamurugan AN, Loganathan G, Bellin MD, et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation 2012; 93: 693.
21. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301.
22. Wijkstrom M, Kenyon NS, Kirchhof N, et al. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720. Transplantation 2004; 77: 827.
23. Ihm SH, Matsumoto I, Sawada T, et al. Effect of donor age on function of isolated human islets. Diabetes 2006; 55: 1361.
24. Papas KK, Suszynski TM, Colton CK. Islet assessment for transplantation. Curr Opin Organ Transplant 2009; 14: 674.
25. Brandhorst H, Brandhorst D, Hesse F, et al. Successful human islet isolation utilizing recombinant collagenase. Diabetes 2003; 52: 1143.
26. + regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 2009; 87: 198.
27. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000. xii, 373 pp.
28. Iezzoni LI. Risk Adjustment for Measuring Health Care Outcomes. 3rd ed. Chicago: Health Administration Press; 2003. xx, 508 pp.